Skip to main content

VICTR Archives

VUMC to lead national study to treat severe COVID complications

May. 6, 2021—The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.

Read more


VUMC aids national effort to repurpose drugs for COVID-19

Apr. 19, 2021—Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19.

Read more


Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization

Mar. 2, 2021—As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.

Read more


Self named VP for Clinical Research Networks and Strategy

Oct. 29, 2020—Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.

Read more


Computer-based study reveals impact of race on health

Oct. 8, 2020—A computer-based method developed at Vanderbilt University Medical Center that scans electronic medical records (EMRs) for genetic contributors to disease has been used for the first time to reveal the impact of race on health.

Read more


Hartmann named first Vice President for Research Integration

Jul. 30, 2020—Katherine Hartmann, MD, PhD, Associate Dean for Clinical and Translational Scientist Development, has been named Vice President for Research Integration for Vanderbilt University Medical Center.

Read more


Rice named to new leadership role for VICTR operations

Jul. 23, 2020—Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).

Read more


VUMC team fills COVID information gaps for web users

Jul. 10, 2020—For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps.

Read more


VICTR named to key role to streamline COVID-19 research response

Jun. 24, 2020—The Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC), has been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19.

Read more


A connection to schizophrenia

Jun. 23, 2020—The insula, a small region of the brain involved in diverse brain functions had widespread dysconnectivity in schizophrenia, Vanderbilt researchers found.

Read more


All of Us program launches cloud-based research platform

Jun. 18, 2020—On May 27, the All of Us Research Program launched the beta version of its cloud-based research platform, the Researcher Workbench.

Read more


Wilkins named CTSA co-principal investigator

Jan. 16, 2020—Consuelo Wilkins, MD, MSCI, has joined Gordon Bernard, MD, as co-principal investigator of Vanderbilt’s Clinical and Translational Science Award.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more